Literature DB >> 2575401

Benorylate hydrolysis by human plasma and human liver.

F M Williams1, U Moore, R A Seymour, E M Mutch, E Nicholson, P Wright, H Wynne, P G Blain, M D Rawlins.   

Abstract

1. Benorylate (4-acetamido phenyl-O-acetylsalicylate) hydrolysis in vitro by human plasma and by human liver microsomes and cytosol has been investigated. 2. Benorylate was hydrolysed by a route involving initial hydrolysis of the acetyl group to yield phenetsal followed by hydrolysis to paracetamol and salicylate. Hydrolysis via acetylsalicylate was minor. 3. Benorylate was more actively hydrolysed by liver cytosol than microsomes and about 10 times faster than plasma. 4. Following a single oral dose benorylate (4 g) to volunteers only salicylate and paracetamol were detected in the plasma. 5. The therapeutic effects of benorylate appear to be mediated by salicylate and paracetamol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575401      PMCID: PMC1380041          DOI: 10.1111/j.1365-2125.1989.tb03563.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Human liver and plasma aspirin esterase.

Authors:  F M Williams; E M Mutch; E Nicholson; H Wynne; P Wright; D Lambert; M D Rawlins
Journal:  J Pharm Pharmacol       Date:  1989-06       Impact factor: 3.765

2.  Comparison of aspirin and benorylate in the treatment of rheumatoid arthritis.

Authors:  D L Beales; H C Burry; R Grahame
Journal:  Br Med J       Date:  1972-05-27

3.  The absorption and metabolism in man of 4-acetamidophenyl-2-acetoxybenzoate (benorylate).

Authors:  A Robertson; J P Glynn; A K Watson
Journal:  Xenobiotica       Date:  1972-07       Impact factor: 1.908

4.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

Review 5.  Serum enzymes of drug metabolism.

Authors:  F M Williams
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

6.  Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components.

Authors:  K D Rainsford; N L Ford; P M Brooks; H M Watson
Journal:  Eur J Clin Invest       Date:  1980-10       Impact factor: 4.686

7.  A comparison of benorylate and naproxen in degenerative arthritis.

Authors:  S R Mayhew
Journal:  Rheumatol Rehabil       Date:  1978-02

8.  The efficacy of benorylate in postoperative dental pain.

Authors:  U Moore; R A Seymour; F M Williams; E Nicholson; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Aspirin metabolism and efficacy in postoperative dental pain.

Authors:  R A Seymour; F M Williams; A Ward; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

  9 in total
  1 in total

1.  Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs.

Authors:  Jiang Li; Shao-Feng Xu; Ying Peng; Nan Feng; Ling Wang; Xiao-Liang Wang
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.